On 19 December 2016, the European Medicines Agency (“EMA”) published an updated version of the EMA guidance document concerning post-authorisation procedural advice for users of ...24 January 2017
Welcome to HL Focus on Regulation
We are delighted to introduce you to our government regulatory blog. In an increasingly complex global market, it’s more important than ever to understand, anticipate, and quickly respond to a wide range of regulatory challenges. Our goal is to use this blog to bring you timely updates on regulatory issues to help you achieve a competitive advantage and minimize regulatory risk. We hope this blog will serve as a key source of information for you in guiding you through the growing array of regulatory issues.
Focus on Regulation has been designed to enable you to subscribe to all or specific topic areas of interest and to be notified of developments in those areas through your email or an RSS feed.
Thank you for joining us, and we look forward to providing focus on the regulatory issues.
- Antitrust Competition and Economic Regulation
- Climate Change
- Food and Agriculture
- Government Contracts
- International Trade and Investment
- Legislation and Political Law Compliance
- Medical Devices
- Pharmaceutical and Biotechnology
- Privacy and Information Management
- Technology Media and Telecoms
- UK and EU Public Law and Policy
Regulation (EU) No 536/2014 of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC (“the Clinical Trials Regulation”) was...24 January 2017
The UK Medicines and Healthcare products Regulatory Agency (“MHRA”) has published a draft strategy for developing pharmacopoeial public quality standards for biological...20 January 2017